This issue addresses a matter of increasing concern to physicians, particularly pediatricians, and other healthcare providers who are charged with the responsibility of protecting patients and the community from the spread of infectious diseases. Because once dangerous, life- threatening diseases have been reduced in incidence or even eliminated with the use of vaccines, a paradoxic increase in concern about these very vaccines has occurred. Dr Robert Chen, Chief of Immunization Safety at the Centers for Disease Control and Prevention, has done an exceptional job of selecting the most pertinent concerns and the appropriate persons to examine them in this issue devoted to vaccine safety in the pediatric community.

The first article, by Drs J. Michael Lane and Joel Goldstein, is concerned with the recent threat of a resurgence of smallpox, for which routine vaccine has not been provided in the United States since 1972. With the possibility of this variola virus being used as part of a bioterrorist arsenal, the questions regarding whether to vaccinate individuals on a wide scale or to limit the scope have been raised, as have concerns about the adverse effects associated with smallpox vaccination. These authors describe various strains of the virus, as well as normal and adverse reactions to the vaccine, with particular attention given to the latter. They also warn that the current population, with the increased prevalence of individuals with immune deficiency and atopic dermatitis, may be at even higher risk for the development of adverse reactions than those reported historically.

As part of addressing reactions patients had when immunized with experiential whole cell pertussis vaccines, researchers developed subunit acellular pertussis vaccines, which subsequently were licensed and now are used exclusively. Although primary doses of the latter vaccines are associated with fewer and less severe reactions than were experienced with the whole cell vaccines, booster doses reportedly have an increased rate and severity of reactions, including complete swelling of the arm or thigh in which the vaccine has been administered. Dr Margaret B. Rennels looks specifically at the rates of these particular reactions, especially in patients given 4 or more doses. She describes results of prospective, multicenter, acellular pertussis trials sponsored by the National Institutes of Health regarding pathogenesis and practical implications. She notes that vaccine manufacturers are developing reduced diphtheria and pertussis antigen content vaccines to be used for booster doses given to adolescents and adults.

In recent years, autistic spectrum disorders have been identified in an alarmingly increasing number of children, and one hypothesis that has influenced parents significantly is that this increase is associated with routine administration of the measles, mumps, rubella (MMR) vaccine. The postulated causal association of MMR vaccine with bowel symptoms in children with autistic spectrum disorders is not the first instance of MMR vaccine being implicated as a cause of bowel-related diseases or syndromes. Dr Elizabeth Miller explains the evolution of hypotheses that have suggested a relational component existing between the receipt of MMR vaccine and the subsequent development of various inflammatory bowel diseases. In this context, she addresses the specific work of Wakefield and colleagues, who hypothesized connections and published reports of studies with biases that subsequently were identified in a publication by another researcher. Dr Miller then summarizes reports from several studies performed using different criteria to test the hypothesis concerning a connection that resulted from Wakefield's allegations. None of the studies could confirm the charges launched against the MMR vaccine, and the prevailing consensus is that not only does no evidence exist of such a connection but that "epidemiological evidence against such an association is compelling."

As noted above, the parental concerns regarding vaccines have taken on new relevance now that the diseases themselves have been eradicated or considerably reduced in incidence by the use of these vaccines. Dr A. Gust and colleagues have examined this paradox, particularly regarding the differences that socioeconomic conditions and education have on parental concepts. The data they present are based on questions administered through the Healthstyles survey conducted in the summer of 2002. For the perception of the risks-versus-benefits of vaccines, they show the influences of income and levels of parent education. These 2 factors also were found to influence parent confidence in vaccines and their children's physicians. In their discussion, the authors explain the importance of recognizing these differences and stress the importance of the role of the physician in disseminating information about vaccines to parents and in helping to develop confidence in the safety of the vaccines.

Surveillance of the safety of various vaccines has been an ongoing challenge to researchers and physicians alike. In Canada, the Immunization Monitoring Program, Active has developed a unique model for accumulating and analyzing surveillance data. Drs David W. Sheifele, Scott A. Halperin and colleagues of CPS/Health Canada and the Immunization Monitoring Program, Active explain in detail the background and origins of the program. They then describe the surveillance methods that were established in 1993, after completion of the pilot study, and subsequent expansions that have occurred. After providing brief summaries of the results of surveillance for numerous associated concerns (eg, *Haemophilus influenzae* type b infections, acute flaccid paralysis, bacille Calmette-Guérin vaccination complications, postimmunization thrombocytopenia, postimmunization febrile seizures, hypotonic-hyporesponsive episodes occurring after immunization, postimmunization encephalopathy, and preventable infections), the authors provide a synopsis of the value, as well as the limitations, of using this type of approach.

One of the mysteries regarding vaccines is the apparent association that has been noted between the administration of high-titer (HT) measles vaccination to children younger than 9 months old and the subsequent increase in incidents of mortality among female recipients. Peter Aaby and Drs Henrik Jensen, Francois Simondon, and Hilton Whittle review the data from 9 studies of HT measles vaccine and examine the observations made of this vaccine in association with childhood mortality. After summarizing the major observations and the various, and often conflicting, interpretations of the data that show increased incidence of mortality among female compared with male recipients in some studies, the authors explain 2 hypotheses that have been given to clarify these differences. Neither of the described hypotheses can account for the principal observations of mortality associated with HT measles vaccinations. They then offer some conclusions that might help provide a better explanation.

In 1999, the Department of Vaccines and Biologicals of the World Health Organization launched an immunization safety priority project to establish a comprehensive system for ensuring the safety of vaccine programs. Dr Philippe Duclos and colleagues provide a provocative explanation of the paradox regarding the past success of immunizations and the current emphasis on concerns regarding safety of various vaccines. They then explain the 4 priorities of the World Health Organization program: to promote and coordinate research and development of safer and simpler delivery systems, to ensure vaccine safety through all the stages of development, to broaden access to safer and more efficient systems for delivering vaccines and managing sharps waste, and to establish an efficient mechanism for detecting serious or potentially serious adverse events following immunizations

This selection of topics is an extremely valuable resource, and Dr Chen is to be commended for his selection of both the timely issues and the authors to address them. Undoubtedly, this subject will be of increasing importance in the days ahead as we confront new challenges associated with safety of vaccines.

For the Case Study, Drs Susan H. Wootten and Gail J. Demmler describe the unusual circumstances surrounding the presentation of an 8-year-old boy who had a history of developmental delay and recurrent otitis media, with left ear pain but no other symptoms. After describing the specific results of examinations on this child who appeared to be well-nourished but was lethargic, disoriented, and verbally unresponsive, the authors ask the question "What is the Diagnosis?" The Denouement provides not only the measures taken to treat this patient but explains the diagnosis and the difficulties physicians face when confronted with cases of this type.

The Special Article addresses the most current information at the time of its writing of the new infectious disease, severe acute respiratory syndrome (SARS). Drs. Gail J. Demmler and B. Lee Ligon provide a history of the disease, as well as the epidemiology, prevention, and concerns for the future.

Dr Lee Ligon provides the Biography on Dr Abraham Jacobi, an appropriate individual for this issue because Jacobi is known for being a vigorous advocate for better health care for children.
